Used in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting neurological disorders. Its structure is valuable in developing drugs that modulate neurotransmitter systems, potentially aiding in the treatment of conditions like depression, anxiety, and epilepsy. Additionally, it serves as a building block in peptide chemistry, enabling the creation of modified peptides with enhanced stability or activity. Its trifluoromethyl group contributes to improved pharmacokinetic properties, making it a crucial component in drug design and development.